NFL Biosciences: Phase II/III clinical trial for NFL-101 for smoking cessation approved in France
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions,...